Free Article Join Over 1 Million Premium Members And Get More In-Depth Stock Guidance and Research

This Bidding War Was a Bidding Skirmish

By Dave Williamson - Apr 9, 2013 at 3:16PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The bidding war for Obagi Medical Products is over, and everyone's a winner.

Though many excited traders had hoped to see the bidding war continue between Valeant Pharmaceuticals (BHC -2.17%) and Merz over Obagi Medical Products (NASDAQ: OMPI) and a subsequent run-up in the stock price of the smaller dermatological products maker, Merz has now walked away from the table, leaving the highly acquisitive Valeant the victor. In this video, Motley Fool health care analyst David Williamson gives us some background on these companies and tells us how Valeant plans to profit from the deal, and describes for investors why this is a win both for Obagi and for Valeant.

Stocks Mentioned

Bausch Health Companies Inc.

BHC

$9.93 (-2.17%) $0.22

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Better Buy: Moderna or Novavax?

Buying These 5 Dividend Stocks Can Make You Nearly $33,000 in Passive Income

Why Cellectis' Shares Rose 22.7% This Week

Why Pfizer Stock Is Rising Today While Moderna and Novavax Are Sliding

This Safe Stock Is Dirt Cheap -- and It's Beating the Market

Motley Fool Returns

Market-beating stocks from our award-winning service.

Stock Advisor Returns

331%

S&P 500 Returns

115%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/21/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Join Stock Advisor

Cumulative Growth of a $10,000 Investment in Stock Advisor

Calculated by Time-Weighted Return since 2002. Volatility profiles based on trailing-three-year calculations of the standard deviation of service investment returns.